Respiratory syncytial virus: Virology, diagnosis, and vaccination G. L. Toms Viral Bronchiolitis In Infancy Pages: 388 - 395
Acute viral bronchiolitis in infancy: Epidemiology and management T. NicolaiA. Pohl Viral Bronchiolitis In Infancy Pages: 396 - 405
Aerosol treatment of respiratory viral disease Vernon KnightBrian E. Gilbert Viral Bronchiolitis In Infancy Pages: 406 - 413
Acute and long-term effects of viral bronchiolitis in infancy John F. Price Viral Bronchiolitis In Infancy Pages: 414 - 421
Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection N. J. C. Snell Viral Bronchiolitis In Infancy Pages: 422 - 429
Smoke-free europe in the year 2000: Nongovernmental action (smoking cessation treatment) Michael Kunze Smoke-Free Europe In The Year 2000 Pages: 433 - 436
Smoking policy in the workplace and other public places Luk Joossens Smoke-Free Europe In The Year 2000 Pages: 437 - 444
The use of transdermal nicotine in smoking cessation Ph. MüllerTh. AbelinD. Mauli Smoke-Free Europe In The Year 2000 Pages: 445 - 453
The role of medical associations against smoking P. Fréour Smoke-Free Europe In The Year 2000 Pages: 454 - 460
Patient education in asthmatic adults H. Worth Patient Education And Rehabilitation In Obstructive Lung Disease Pages: 463 - 468
Patient education in asthmatic children Richard KraemerSilvana SpeckMartin H. Schöni Patient Education And Rehabilitation In Obstructive Lung Disease Pages: 469 - 473
Guidance of children and adolescents with cystic fibrosis Jorrit GerritsenHan van der LaagKlaas Knol Patient Education And Rehabilitation In Obstructive Lung Disease Pages: 474 - 480
Exercise training during pulmonary rehabilitation in chronic obstructive pulmonary disease P. N. R. DekhuijzenC. L. A. van HerwaardenH. Th. M. Folgering Patient Education And Rehabilitation In Obstructive Lung Disease Pages: 481 - 488
Living conditions of serious chronic respiratory insufficiency patients treated at home on oxygen therapy or assisted ventilation J. F. MuirF. Laumonier Patient Education And Rehabilitation In Obstructive Lung Disease Pages: 489 - 494
Pulmonary rehabilitation in an asthma clinic T. A. W. van der SchootA. A. Kaptein Patient Education And Rehabilitation In Obstructive Lung Disease Pages: 495 - 501
Target-flow inspiratory muscle training at home and during pulmonary rehabilitation in COPD patients with a ventilatory limitation during exercise P. N. R. DekhuijzenH. Th. M. FolgeringC. L. A. van Herwaarden Patient Education And Rehabilitation In Obstructive Lung Disease Pages: 502 - 508
Proposal for a European COPD network F. Smeets Patient Education And Rehabilitation In Obstructive Lung Disease Pages: 509 - 513
A program for the prevention of lung diseases Karl H. Harnoncourt Patient Education And Rehabilitation In Obstructive Lung Disease Pages: 514 - 519
Discovery ofα 1-antitrypsin deficiency Sten Eriksson α1-Antitrypsin Deficiency: Diagnosis, Treatment, And Control Pages: 523 - 529
The molecular structure and pathology ofα 1-antitrypsin R. W. Carell α1-Antitrypsin Deficiency: Diagnosis, Treatment, And Control Pages: 530 - 534
The epidemiology ofα 1-antitrypsin deficiency D. C. S. Hutchison α1-Antitrypsin Deficiency: Diagnosis, Treatment, And Control Pages: 535 - 542
α1-Antitrypsin deficiency—diagnosis, treatment, and control: Identification of patients A. Sonia Buist α1-Antitrypsin Deficiency: Diagnosis, Treatment, And Control Pages: 543 - 551
The protease-antiprotease balance within the human lung: Implications for the pathogenesis of emphysema James E. GadekEric R. Pacht α1-Antitrypsin Deficiency: Diagnosis, Treatment, And Control Pages: 552 - 564
Strategies for aerosol therapy ofα 1-antitrypsin deficiency by the aerosol route Richard C. HubbardRonald G. Crystal α1-Antitrypsin Deficiency: Diagnosis, Treatment, And Control Pages: 565 - 578
Decline in pulmonary function in patients with α1-antitrypsin deficiency Torben EvaldAsger DirksenAxel Kok-Jensen α1-Antitrypsin Deficiency: Diagnosis, Treatment, And Control Pages: 579 - 585
Criteria forα 1-antitrypsin substitution K. ViskumA. Kok-Jensen α1-Antitrypsin Deficiency: Diagnosis, Treatment, And Control Pages: 586 - 591
Postural mechanisms in asthma: Importance for nocturnal symptoms Björn Mossberg Management Of Chronic Airflow Obstruction Pages: 595 - 598
Gas exchange abnormalities in asthma R. Rodriguez-Roisin Management Of Chronic Airflow Obstruction Pages: 599 - 605
The role of chest physiotherapy in mucus hypersecretion Demetri Pavia Management Of Chronic Airflow Obstruction Pages: 614 - 621
Mucolytics: When dispensable, when necessary? P. Dorow Management Of Chronic Airflow Obstruction Pages: 622 - 626
Management of chronic airway obstruction: Theophylline—Is it still necessary? Dieter UkenaGerhard W. Sybrecht Management Of Chronic Airflow Obstruction Pages: 627 - 633
Management of asthma and chronic airflow limitation: Are methylxanthines obsolete? Michael T. NewhouseAndy Lam Management Of Chronic Airflow Obstruction Pages: 634 - 641
Inhalation delivery of asthma drugs Heinrich Matthys Development Of Inhalation Therapy Pages: 645 - 652
Use of different inhalation devices in children Søren PedersenSven Mortensen Development Of Inhalation Therapy Pages: 653 - 657
The adult patient’s difficulties with inhalers G. K. Crompton Development Of Inhalation Therapy Pages: 658 - 662
Fate of human albumin microsphere and spherocyte radioaerosols in the human tracheobronchial tree T. TodiscoM. DottoriniE. V. Cosmi Aerosol Therapy: Uses Other Than In Asthma Pages: 665 - 671
Aerosol deposition in the alveolar space Gérard Huchon Aerosol Therapy: Uses Other Than In Asthma Pages: 672 - 676
Aerosols for systemic treatment Dieter Köhler Aerosol Therapy: Uses Other Than In Asthma Pages: 677 - 684
Aerosol therapy in AIDS Stephen P. NewmanAnita K. Simonds Aerosol Therapy: Uses Other Than In Asthma Pages: 685 - 691
Value of67gallium scintigraphy in primary diagnosis and follow-up of opportunistic pneumonia in patients with AIDS E. MoserK. TatschF. D. Goebel Aerosol Therapy: Uses Other Than In Asthma Pages: 692 - 703
Biological activity of bacterial surface components: Bacterial extracts and defined bacterial cell wall components as immunomodulators W. G. BesslerB. KleineG. Jung The Local Pulmonary Defense System: Activity Of Bacterial Fractions Pages: 707 - 715
Influence of a bacterial extract on antigen presentation and protection against experimental infections R. FontangesC. BottexM. F. Burckhart The Local Pulmonary Defense System: Activity Of Bacterial Fractions Pages: 716 - 719
Activation of natural killer cells and cytokine production in humans by bacterial extracts (OM-85 BV) J. WybranM. LibinL. Schandene The Local Pulmonary Defense System: Activity Of Bacterial Fractions Pages: 720 - 725
Effects of a bacterial extract on local immunity of the lung in patients with chronic bronchitis B. EmmerichH. P. EmslanderK. Pachmann The Local Pulmonary Defense System: Activity Of Bacterial Fractions Pages: 726 - 731
Immunomodulation with bacterial extracts in respiratory diseases A. G. Palma-CarlosM. L. Palma-Carlos The Local Pulmonary Defense System: Activity Of Bacterial Fractions Pages: 732 - 736
Preventive effects of an immunostimulating product on recurrent infections of chronic bronchitis in the elderly N. DebbasJ. P. Derenne The Local Pulmonary Defense System: Activity Of Bacterial Fractions Pages: 737 - 740
Natural history of obstructive airways disease and hypoxia: Implications for therapy P. Howard Long-Term Oxygen Therapy Pages: 743 - 750
Chronic lung disease in the sleep apnea syndrome Eugene C. Fletcher Long-Term Oxygen Therapy Pages: 751 - 761
Survival in chronic obstructive pulmonary disease after diagnosis of pulmonary hypertension related to long-term oxygen therapy G. WuertembergerJ. ZielinskyH. Matthys Long-Term Oxygen Therapy Pages: 762 - 769
